Pandemic treaty: Draft urges cooperation, equity, transparency but misses independent monitoring

Draft has evolved from a working document circulated earlier this year in July and builds on the comments made by member states, domain experts …

India readies for COVID-19 vaccination but vexed questions on the solution remain

The risks the country needs to prepare for, precautions it needs to take, the logistics required and, above all, the implications of it all for …

Omicron can partially evade vaccines, booster dose needed : Studies

Vaccinated persons who had contracted COVID-19 in the past have better protection against the disease  

Trade barriers, raw material scarcity can dent hopes for 10 billion COVID-19 vaccines in production

Experts warned of short supply of crucial raw materials; late delivery of bio-reactor giant plastic bags can set back production by weeks, …

Can activism check Big Pharma’s profit motives?

As prices of life-saving drugs skyrocket, people from diverse fields are getting together to fight Big Pharma

Update COVID-19 vaccine to target omicron variants: Advisory panel to USFDA

Unclear which combination of updated vaccine will work best; body expected to decide by July

Vaccines work just fine without side effects says a new Lancet study

Only one in four people experience mild, short-lived systemic side-effects after receiving either the Pfizer Inc or the Oxford University-…

Vaccine Watch: 5 dead in Serum Institute fire; UAE okays Sputnik

PM likely to be vaccinated in March or April, doctor in Shivamogga dies two days after receiving jab and Israel denies vaccine efficacy fears

The Pfizer vaccine may not be the best choice for frail people, but it’s too early to make firm conclusions

While the deaths of elderly people in Norway are sad, they shouldn’t be cause for alarm. This actually tells us the vaccine is stimulating …

Pfizer’s COVID-19 vaccine becomes first to get emergency authorisation

UK government gives nod on basis of interim results, vaccine to be made available by next week  

Making COVID-19 vaccines in Africa: Advances and sustainability issues

Demand, market for locally produced vaccines critical for sustainability of 15 COVID-19 vaccines manufacturing facilities

COVID-19 surge: Why has China not attained herd immunity despite high vaccination coverage?

Germany, South Korea, Vietnam are also reporting increase in COVID-19 cases despite extensive vaccination

COVID vaccines: How to make sense of reports on their effectiveness

Real-world trials come with some problems: The target of vaccination, what time it was rolled out and emerging variants

Delaying the second COVID-19 vaccine dose: A medical expert answers key questions

The uncertainty is around how long the protective effect of the first dose will last without a second shot

COVID-19 vaccines are coming – how will we know they work and are safe?

The results of the Pfizer vaccine trial are highly promising. But the road to eradicating the coronavirus is likely to be long and difficult

Why other African countries need to guard against South Africa COVID-19 variant

WHO and African Centres for Disease Control to strengthen genomic surveillance capacities

Dummy’s guide to how trade rules affect access to COVID-19 vaccines

The WTO is considering whether to temporarily waive certain rules about TRIPS, to allow more countries access to vaccines, drugs needed to …

Effectiveness of COVID-19 vaccines against infection, severe disease declined with new variants; here's how

AstraZeneca vaccine provided least protection against infection, showed most rapid decline

WATCH: Will mixing COVID-19 vaccines be effective?

Some early studies have shown that combining vaccines produce a better immune response. But the efficacy of the vaccine combination is yet to be …

COVID-19 vaccines: How Pfizer and Moderna’s 95% effective mRNA shots work

Should we expect the pandemic to be over once a vaccine is available for public use? Not exactly. A vaccine will not be perfect, and it takes …

Moderna’s COVID vaccine reports 95% efficacy. It means we might have multiple successful vaccines

It opens the door to the possibility we might have many successful vaccines, and be able to tailor different vaccines to people with different needs

COVID-19: Pfizer, AstraZeneca efficacy significantly reduced against omicron, says UK health agency 

Omicron is displaying growth advantage over delta and is poised to become dominant variant in UK

Covaxin effective against UK Strain: What does this mean in absence of efficacy data?

Being a whole-virus vaccine doesn’t give Bharat Biotech product any advantage at this stage, say experts

Lateral Thoughts: Waiting for bad news

Adverse reactions are part and parcel of vaccination. We can know about safety of COVID-19 vaccines being used in India only after people receive …

COVID-19 immunity: how long does it last?

In UK’s second wave, previously infected health workers were either completely protected from reinfection or were asymptomatic